News - Page 4 of 13 - Xtant Medical

Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment

October 11, 2022

BELGRADE, Mont. , Oct. 11, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the second and final tranche of its previously announced

Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment

August 31, 2022

BELGRADE, Mont. , Aug. 31, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the first tranche of its previously announced private

Xtant Medical Announces $9.75 Million Private Investment

August 24, 2022

Upon completion of first closing, Stavros Vizirgianakis to become Non-Executive Chairman BELGRADE, Mont. , Aug. 24, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,

Xtant Medical Announces Second Quarter 2022 Financial Results

August 4, 2022

BELGRADE, Mont. , Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2022

Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

July 28, 2022

BELGRADE, Mont. , July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended

Xtant Medical Announces First Quarter 2022 Financial Results

May 5, 2022

BELGRADE, Mont. , May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2022 .

Xtant Medical Appoints Scott Neils as Chief Financial Officer

May 2, 2022

BELGRADE, Mont. , May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Chief Financial Officer, effective June

Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

April 28, 2022

BELGRADE, Mont. , April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended

Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022

March 15, 2022

BELGRADE, Mont. , March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , President and Chief Executive Officer, will present at

Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results

March 8, 2022

BELGRADE, Mont. , March 08, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended

Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

March 1, 2022

BELGRADE, Mont. , March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and

Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference

January 4, 2022

BELGRADE, Mont. , Jan. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne , Chief Executive Officer, will present at the H.C.